Pharmaceutical Costs

Maryland Lawmakers Submit Drug Cost Review Bill Based on NASHP’s Model Legislation

ANNAPOLIS — State lawmakers are scheduled to introduce a bill today that empowers Maryland to regulate prescription drug costs by evaluating the affordability of certain drugs and imposing limits on what the state and commercial health plans will pay them. Based on model legislation created by the National Academy for State Health Policy (NASHP), the […]

Read More
  • Maps
    State Legislative Action to Lower Pharmaceutical Costs

    State Legislative Action to Lower Pharmaceutical Costs

    *Updated Oct. 4, 2018* Find the status of state legislation to curb prescription drugs below. Use the category button to search by type of legislation or click on a state to view its drug bills. Click here to view a chart listing legislation by state. View state action in 2017 and 2015-2016. Know about a bill to add or have information to […]

    Read More
  • Utah State Legislator Introduces Bill to Import Prescription Drugs from Canada, Based on NASHP Model Legislation

    Utah State Legislator Introduces Bill to Import Prescription Drugs from Canada, Based on NASHP Model Legislation

    Salt Lake City, Utah: Today, Republican state legislator Norman Thurston introduced groundbreaking legislation to create a safe, state-run prescription drug importation program that would import high-cost drugs from Canada, where prescription drugs cost 30 percent less than in the United States. The proposal for a whole-sale importation program of select, higher-cost drugs that are already […]

    Read More
  • State Health Policy Blog
    Reining in Rx Drug Costs: What States Achieved in 2017 and Where They’re Heading in 2018

    Reining in Rx Drug Costs: What States Achieved in 2017 and Where They’re Heading in 2018

    In a year of tense partisan debate over the future of health care, one issue has achieved rare bipartisan agreement — the need to curb rising prescription drug costs. Polls show again and again that Americans, regardless of political affiliation, view the high costs of drugs as one of their chief health care concerns. Reviews […]

    Read More
  • Academy of Sciences Recommends Federal Strategies to Lower Rx Prices, But Some States Are Already Taking Action

    The National Academy of Sciences recently released a report recommending several strategies to curb prescription drug costs that attempt to strike a balance between reining in prices while fostering continued drug development and innovation. Several of the academy’s recommendations are already getting trial runs in states, which are experimenting with innovative cost-savings approaches in order […]

    Read More
  • Is It Safe and Cost-Effective to Import Drugs from Canada?

    Is It Safe and Cost-Effective to Import Drugs from Canada?

    States are considering importing prescription drugs from Canada, but is it safe? Will it save money? Can it be done? Three, easy-to-read infographics explain what state leaders need to know if they’re interested in drug importation legislation. 1. Is it safe to import drugs from Canada? Yes, 40 percent of all drugs sold in the […]

    Read More
  • Publications

    The Dormant Commerce Clause: What Impact Does It Have on the Regulation of Pharmaceutical Costs?

    When states pass laws designed to control prescription drug costs, the pharmaceutical industry often responds with lawsuits claiming states are hindering interstate commerce and violating the federal Dormant Commerce Clause (DCC). NASHP’s legal experts believe states can craft drug cost policies that can withstand industry challenges. This brief by Anna Zaret and Darien Shankse provides insight and […]

    Read More
  • State Health Policy Blog
    How States Can Avoid Dormant Commerce Clause Legal Challenges When Regulating Drug Costs

    How States Can Avoid Dormant Commerce Clause Legal Challenges When Regulating Drug Costs

    New state laws designed to control the costs of brand-name and generic prescription drugs often face legal challenges from the pharmaceutical industry. These lawsuits can vary depending on the individual state law, but recent industry lawsuits analyzed by the National Academy for State Health Policy (NASHP) share a common legal thread – drug manufacturers and […]

    Read More
  • State Health Policy Blog
    Utah’s Norman Thurston Takes a Red State Approach to Lower Rx Costs with a Bill to Import Drugs from Canada

    Utah’s Norman Thurston Takes a Red State Approach to Lower Rx Costs with a Bill to Import Drugs from Canada

    For more than a decade, Utah State Legislator and Director of the Office of Health Care Statistics Norman Thurston has worked to reform his state’s health care system, including its Medicaid program, and is considered one of the state’s “go-to” health care policymakers. Thurston, a Republican, has worked to reduce state spending on prescription drugs and […]

    Read More
  • An Interview with Drug Cost Control Advocate Richard Gottfried

    At NASHP’s 30th State Health Policy Conference, state leaders from legislative and executive branches across the nation gathered to talk about what they are doing to manage escalating prescription drug costs in their states. Several states have recently passed or proposed legislation to force more transparency in drug pricing or to try to regulate drug […]

    Read More